1. Feduniw S, Warzecha D, Szymusik I, Wielgos M. Epidemiology, prevention and management of early postpartum hemorrhage - a systematic review. Ginekologia Polska. 2020;91(4):38-44.
2. Thompson JF, Heal LJ, Roberts CL, Ellwood DA. Women's breastfeeding experiences following a significant primary postpartum haemorrhage: A multicentre cohort study. International Breastfeeding Journal. 2010;5(5):1.
3. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. 2012. www.who.int/publications/i/item/9789241548502.
4. CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;26;377(9771):1096-101;1101.e1-2.
5. Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105-16.
6. Novikova N, Hofmeyr J, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No: CD007872.
7. Shakur H, Beaumont D, Pavord S, Gayet-Ageron A, Ker K, Mousa HA. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database of Systematic Reviews 2018, Issue 2. Art. No: CD012964.
8. Rohwer C, Rohwer A, Cluver C, Ker K, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage after caesarean section. Cochrane Database of Systematic Reviews 2024, Issue 2. Art. No: CD016278.
9. Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM, et al, For the Eunice Kennedy Shriver National Institute of Child Health, Human Development Maternal-Fetal Medicine Units Network. Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery. New England Journal of Medicine. 2023;388(15):1365-75